No idea if it’s good, but it’s not a mature business so the asx might be reluctant to let them back on. Whatever the business is it has to be better than what they currently have.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
